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Abstract 
Objective: Although a 5%–10% loss in the baseline weight has been associated with 
improvement in obesity-related disorders, only a few studies have explored the factors to 
alleviate metabolic syndrome (MS). This study aimed to determine the factors that alter MS 
components in overweight Japanese women. 5 
Methods: Between 1999 and 2006, 323 Japanese women aged 24–67 with body mass 
indices of 25–40 kg/m2 and the presence of at least 1 component of MS were recruited from 
Ibaraki and Chiba. The participants were enrolled in a 3-month weight-loss program with a 
low-calorie diet with or without exercise. The factors to alleviate MS components were explored 
using classification and regression tree (CART) analyses. 10 
Results: Of the 323 participants, 309 completed the weight-loss program and were 
included in the analyses. The CART analyses revealed that a weight reduction of 8.1% in baseline 
body weight was sufficient to improve at least 1 component of MS. Similarly, classification trees 
were generated for improvement in abdominal obesity (essential factor: ≥13.0% weight loss), 
hypertension (essential factor: baseline age, ≤41.5 years), and hyperglycemia (essential factor: 15 
≥13.2% weight loss). 
Conclusion: These results suggest that moderate weight loss of 8%–13% contributes 
to improving the MS components in overweight Japanese women. 
 
Key words: metabolic diseases; intervention; diet; nutrition; exercise 20 
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Introduction 
 Metabolic syndrome (MS) is characterized by inter-related risk factors (Grundy et al., 
2005) that increase susceptibility to cardiovascular diseases (Lakka et al., 2002; Hu et al., 2004), 
type 2 diabetes (Laaksonen et al., 2002; Lorenzo et al., 2003), and all-cause mortality (Lakka et 
al., 2002; Hu et al., 2004). Weight loss by caloric restriction combined with exercise is commonly 5 
employed for the management of MS. Recent systematic reviews have reported that moderate 
weight loss (5%–10% of the initial body weight) is associated with improvement in 
obesity-related cardiovascular and metabolic abnormalities (Aucott et al., 2004, 2005; Poobalan 
et al., 2004) and all-cause mortality (Poobalan et al., 2007). However, only a few studies have 
explored the factors that are necessary to alleviate MS. 10 
In Japan, MS is acknowledged as a major public health concern that has been addressed 
by developing country-specific diagnostic criteria and guidelines (Fujita, 2008). The definition of 
MS in Japan differs from those of the World Health Organization (Alberti and Zimmet, 1998), the 
National Cholesterol Education Program (NCEP) (Expert Panel on Detection, Evaluation, and 
Treatment of High Blood Cholesterol in Adults, 2001), and International Diabetes Federation 15 
(IDF) (Alberti et al., 2005). In the Japanese definition (The Examination Committee of Criteria 
for “Metabolic Syndrome” in Japan, 2005), abdominal obesity accompanies any 2 of the 
following features: dyslipidemia (triglycerides ≥ 150 mg/dL and/or high-density lipoprotein 
cholesterol < 40 mg/dL), hypertension (systolic blood pressure ≥ 130 mmHg and/or diastolic 
blood pressure ≥ 85 mmHg), and hyperglycemia (fasting plasma glucose ≥ 110 mg/dL). 20 
Abdominal obesity is assessed by measuring the visceral fat area (VFA) by computed 
tomography (CT). VFA ≥ 100 cm2 indicates the risk of obesity-related disorders (dyslipidemia, 
hypertension, and hyperglycemia) and corresponds to a waist circumference of ≥85 cm in men 
and ≥90 cm in women (The Examination Committee of Criteria for ‘Obesity Disease’ in Japan, 
Japan Society for the Study of Obesity, 2002). Although the IDF acknowledged specific cut-offs 25 
for different genders and ethnicities (Alberti et al., 2005), the Japanese movement towards 
country-specific diagnostic criteria for MS is controversial (Banerjee and Misra, 2007; Fujita, 
2008). Here, however, we used the Japanese criteria in response to the Japanese national-level 
movement. 
We aimed to determine the factors alleviating MS components in overweight Japanese 30 
women who underwent a 3-month weight-loss intervention consisting of a low-calorie diet with 
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or without exercise, using classification and regression tree (CART) analyses (Bartali et al., 2008; 
Gu et al., 2006; Miyaki et al., 2002). Menopausal status, age, degree of obesity at baseline, 
percentage weight loss from baseline, and adding exercise to low-calorie diet were the potential 
contributory factors for alleviating MS through weight loss. 
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Methods 
Participants 
In 1999–2006, we recruited 563 Japanese women in Ibaraki and Chiba through 
advertisements in local newspapers for a 3-month weight-loss program. Of these, 323 women 
(age, 24–67 years; BMI, 25–40 kg/m2) who had at least 1 component of MS were selected (Fig. 5 
1). Of these, 124 were postmenopausal and 199 premenopausal. Menopause is defined as the 
absence of menses for at least 12 months. This study conformed to the Helsinki Declaration 
principles and was approved by the Review Board of the University of Tsukuba. The participants 
provided informed written consent. 
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Research procedures 
We implemented 2 weight-loss programs: (i) a low-calorie diet alone (group D, n = 118) 
and (ii) a diet-plus-exercise program (group DE, n = 205). Participants were assigned to either 
program according to their personal preferences. Assays and measurements were performed 
before and after the 3-month intervention. An explorative approach was used to determine the 15 
factors alleviating MS and its components. 
 
Measurements 
Anthropometric variables. Body weight was measured to the nearest 0.1 kg using a 
digital scale (TBF-551; Tanita, Tokyo, Japan), and height to the nearest 0.1 cm on a wall-mounted 20 
stadiometer (YG-200; Yagami, Nagoya, Japan). Body mass index (BMI) was calculated as (body 
weight)/(height)2 (kg/m2). Waist circumference was measured at the umbilicus level to the nearest 
0.1 cm using flexible plastic tape when the subjects were standing. 
 
VFA by CT. VFA was measured at the umbilicus level by CT (SCT-6800TX; Shimadzu, 25 
Tokyo, Japan) when the subjects were supine, and calculated using the FatScan software 
(N2system, Osaka, Japan) (Yoshizumi et al., 1999). 
 
Blood pressure and biochemical blood assay. Blood pressure was measured using a 
manual sphygmomanometer (SM-100; Ars, Tokyo, Japan) in the seated position after a 20-minute 30 
rest period. Approximately 10 mL blood was drawn from each subject after overnight fasting. 
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Fresh samples were used for the enzymatic analysis of triglycerides, and the fasting plasma 
glucose was assayed using glucose oxidase. Serum high-density lipoprotein cholesterol was 
measured using heparin-manganese precipitation. 
 
MS components. The Japanese criteria (The Examination Committee of Criteria for 5 
“Metabolic Syndrome” in Japan, 2005) were used to evaluate the prevalence of MS and its 
components. The number of MS components (0–4) was also counted. 
 
Intervention 
Dietary protocol. All participants were instructed to restrict their energy intake to 10 
approximately 1200 kcal/d. The energy intake per meal (3 times per day) was 80 kcal each from 
eggs and/or dairy products; meat, fish, and/or soybean products; and vegetables and fruits, and 
160 kcal from carbohydrates and oils. They maintained a daily food diary during the 3-month 
intervention and attended group-based 90-minute weekly lectures on low-calorie diets, where 
dieticians encouraged weight loss through nutrition education and dietary behavior modification. 15 
 
Exercise protocol. In addition to dieting, group DE participants performed 3 aerobic 
exercise sessions (bench stepping and/or walking) every week in a fitness room and/or outdoors. 
The exercise intensity was set such that it raised the subjects’ heart rate to 40%–85% of the heart 
rate at their V
．
O2max, which was determined during a graded exercise test using a cycling 20 
ergometer at the baseline, or from 9 (very light) to 17 (very hard) on the Borg scale (Borg, 1973). 
The exercise intensity was gradually increased during the intervention. The average energy 
expenditure was approximately 150 kcal/d (Okura et al., 2003). 
 
Statistical analyses 25 
Baseline characteristics and changes during the intervention period were recorded 
separately for groups D and DE. Values are represented as means ± standard deviation. Paired t 
tests were used to analyze differences between the quantitative variables before and after the 
intervention. Differences in the prevalence of MS and its components were analyzed using 
McNemar’s tests, and those in the number of MS components using Wilcoxon signed-rank tests. 30 
CART analyses were used to explore the successive binary divergences of the 
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explanatory variables (menopausal status, baseline age, baseline BMI, weight-loss program, and 
percentage weight loss) to identify the subgroups on the basis of their homogeneity in 
representing an improvement in MS and its components. CARTs are binary classification trees 
constructed by iteratively splitting the subsets of the dataset using all the explanatory variables to 
create 2 subgroups. Each explanatory variable is evaluated to identify the optimum cutoff point 5 
(continuous variables) or groupings (nominal variables) based on the improvement score 
(calculated by the Gini criterion function) at each branch point, and the variable with the best 
improvement is selected for the split. The process is repeated recursively until one of the 
following stopping rules is triggered: the maximum tree depth is reached (2 in this study) or no 
more splits can be produced because all terminal subgroups satisfy 1 or more of the following 10 
conditions: (a) no significant explanatory variable is left to split the subgroup, (b) the number of 
cases in the terminal subgroup is less than the minimum split number (30 in this study), and (c) if 
an upper subgroup were to be split, the number of cases in 1 or more lower subgroup would be 
less than the minimum number of cases (15 in this study). At each branch point, P values were 
represented from chi-square tests. Fisher’s exact tests were performed for the branch points in 15 
which the expected value for at least 1 of the 2 × 2 cells was less than 5 (P′ value). 
Data were analyzed using SPSS statistical software (version 16.0J; SPSS, Chicago, IL), 
with the statistical significance set at 5%. 
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Results 
A total of 309 participants completed the study (n = 115 and n = 194 in groups D and DE, 
respectively). Three participants from group D and 11 from group DE withdrew from the 
respective programs. Table 1 presents the baseline characteristics and changes that occurred 
during the 3-month weight-loss intervention in the 309 participants. The average weight loss was 5 
11.9% ± 4.2%. The prevalence of MS and its components significantly decreased in both the 
groups. 
The CART analysis results are shown in Figs 2–5. The first table of Fig. 2 shows that 
weight loss alleviated at least 1 component of MS in 225 of the 309 participants (72.8%). The 
best factor to alleviate at least 1 component of MS was ≥8.1% weight loss. At least 1 component 10 
of MS was improved in 199 of the 250 participants with ≥8.1% weight loss (79.6%) and in only 
26 of the 59 participants (44.1%) with <8.1% weight loss. The baseline BMI (cutoff: 25.85 
kg/m2) was used to subdivide the ≥8.1% weight loss group. At least 1 component of MS was 
improved in 37 of the 40 participants with a baseline BMI of ≤25.85 kg/m2 (92.5%) and in 162 of 
the 210 participants with a BMI of >25.85 kg/m2 (77.1%). 15 
Fig. 3 shows the classification tree demonstrating the improvement in abdominal obesity. 
The first table indicates that 203 women had abdominal obesity at baseline, which was alleviated 
through weight loss in 117 (57.6%). The weight loss (cutoff: 13.0%) was the best factor for 
division. Abdominal obesity was improved in 65 of the 82 participants with ≥13.0% weight loss 
(79.3%) and in 52 of the 121 participants with <13.0% weight loss (43.0%). In the subgroup 20 
exhibiting ≥13.0% weight loss, the baseline age (cutoff: 52.5 years) was the best factor for further 
division, exhibiting reduced abdominal obesity in 41 of 42 (97.6%) vs. 24 of 40 (60.0%) 
participants in the ≤52.5- and >52.5-year groups, respectively. Further, in the subgroup exhibiting 
<13.0% weight loss, the baseline BMI (cutoff: 26.89 kg/m2) was the best factor for the 
subdivision: exhibiting reduced abdominal obesity in 24 of 31 (77.4%) vs. 28 of 90 (31.1%) in 25 
the ≤26.89 kg/m2 and >26.89 kg/m2 groups, respectively. 
Fig. 4 shows the classification tree demonstrating improvement in hypertension. The 
first table shows that 240 participants had hypertension at baseline, which was alleviated via 
weight loss in 113 participants (47.1%). The baseline age (cutoff: 41.5 years) was the best factor 
for alleviating hypertension. Hypertension was alleviated in 26 of the 35 participants below 41.5 30 
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years (74.3%) and in 87 of the 205 participants over 41.5 years (42.4%). In the >41.5-year group, 
hypertension was reduced in 23 of the 79 participants who followed the diet without exercise 
(29.1%) and in 64 of the 126 who followed the diet plus exercise (50.8%). 
 Fig. 5 shows the classification tree for improvement in hyperglycemia. The first table 
shows that 57 participants had baseline hyperglycemia, which was alleviated through weight loss 5 
in 34 participants (59.6%). The weight loss (cutoff: 13.2%) was the best factor for alleviating 
hyperglycemia. Hyperglycemia was alleviated in 14 of the 15 participants with ≥13.2% weight 
loss (93.3%) and in 20 of the 42 participants with <13.2% weight loss (47.6%). 
 All classifications were statistically significant by chi-square or Fisher’s exact tests. No 
classification trees were generated for MS alleviation (69 participants had baseline MS that was 10 
alleviated by weight loss in 59 (85.5%)) and dyslipidemia (83 participants had baseline 
dyslipidemia that was alleviated by weight loss in 67 (80.7%)). 
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Discussion 
We used the CART algorithm to determine the factors alleviating the MS components in 
overweight Japanese women who participated in a 3-month weight-loss program that included a 
low-calorie diet with or without exercise. The best factor that alleviated at least 1 component of 
MS was 8.1% weight loss, which is similar to values reported in recent systematic reviews 5 
(5%–10%) for improvement in obesity-related cardiovascular and metabolic abnormalities and 
all-cause mortality (Aucott et al., 2004, 2005; Poobalan et al., 2004, 2007). Further, recent 
clinical trials employing NCEP criteria determined that 7%–8% weight loss reduced the 
prevalence of MS in obese men and women (Phelan et al., 2007) and MS development in men 
and women with impaired glucose tolerance (Orchard et al., 2005). Therefore, our findings are 10 
reasonable and could be set as the target value for improving MS. 
Greater weight reduction was required for improving abdominal obesity (≥13.0%) and 
hyperglycemia (≥13.2%). Participants aged ≤41.5 years were the best candidates for alleviating 
hypertension, and for those aged >41.5 years, exercise combined with a low-calorie diet 
contributed to alleviating hypertension. Relatively higher weight loss is required for overweight 15 
Japanese women in order to improve abdominal obesity or hyperglycemia. For improving 
hypertension through weight loss, the importance of exercise becomes clinically evident in the 
case of women aged >41.5 years. Thus, the CART analyses present a possible strategy for the 
management of metabolic risk factors, especially for group planning purposes, that is, it provides 
a target weight-loss value under each baseline condition. The additional chi-square and Fisher’s 20 
exact tests revealed that all the classifications were statistically significant indicating that our 
classification efficiently categorizes overweight Japanese women into more or less improved 
groups in as distinct a manner as possible. 
 
Study limitations and strengths 25 
Although this study aimed to determine the factors alleviating MS in overweight 
Japanese women, no classification tree was generated for this because of low prevalence (total 
prevalence, 22%) and small available datasets (n = 69). Classification trees were generated for 
the alleviation of at least 1 component of MS and for improving abdominal obesity, hypertension, 
and hyperglycemia individually. However, these findings are limited to this group of overweight 30 
Japanese women who participated in a 3-month low-calorie-diet weight-loss program with or 
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without exercise. Therefore, the results of this study may not be generalized. 
Since the CART algorithm was originally designed for large sample sizes, a larger 
sample size would result in more diverse classification trees. Sufficiently large samples would be 
divided into a training sample and a testing sample from which the classification tree is generated, 
and on which the tree is tested for cross-validation, respectively. Our sample size was sufficiently 5 
large to apply CART analyses to determine the factors alleviating MS in overweight Japanese 
women, but it was insufficient to divide into training and testing samples. Further studies with 
larger sample sizes are required. 
Exercise combined with low-calorie diet efficiently alleviated hypertension in a 
subgroup of women aged >41.5 years. However, this outcome is probably biased because the 10 
participants were non-randomly assigned to groups D and DE. The wide range of exercise 
intensities, which was prescribed, also hinders the generalization of the relationship. Further, it is 
possible that the CART algorithm might have oversimplified the relationship between weight loss 
and medical co-morbidity. The present study does not deny the possibility of an improvement in 
hypertension with the weight-loss regimen in patients over 41.5 years. 15 
Numerous algorithms exist for predicting continuous or categorical variables from a set 
of continuous and/or categorical factors. However, CART has 2 advantages over alternative 
techniques. First, it is very simple to interpret the results. It is easier to evaluate a few logical 
if-then conditions than to compute classification scores for each possible group. Second, CART 
analysis is nonparametric and nonlinear, and is particularly well suited to identify a hierarchical 20 
order of potentially complex interactions between a set of continuous and/or categorical variables. 
Since few attempts have been made to explore the conditions for alleviating MS, our findings 
appear important. 
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Conclusion 
 Our interventional study comprising a 3-month weight-loss program with a low-calorie 
diet with or without exercise suggests that moderate weight loss of 8–13% helps in reducing MS 
components in overweight Japanese women. Baseline conditions (age and BMI) could also be 
important factors. However, further studies using an ideal study design are required to confirm 5 
these findings. 
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Figure legends 
 
Fig. 1. Flow diagram of the participants (Ibaraki and Chiba, Japan: years 1999–2006). 
 
Fig. 2. Classification tree of participants for decreasing at least 1 component of metabolic 5 
syndrome. The participants in category 0 continued to exhibit the same number of the 
components, while those in category 1 exhibited a decreased number of the components (Ibaraki 
and Chiba, Japan: years 1999–2006). 
 
Fig. 3. Classification tree of participants for improvement in abdominal obesity. The participants 10 
in category 0 continued to exhibit abdominal obesity, while those in category 1 showed reduced 
abdominal obesity (Ibaraki and Chiba, Japan: years 1999–2006). 
 
Fig. 4. Classification tree of participants for improvement in hypertension. The participants in 
category 0 continued to exhibit hypertension, while those in category 1 showed an improvement 15 
in hypertension (Ibaraki and Chiba, Japan: years 1999–2006). 
 
Fig. 5. Classification tree of participants for improvement in hyperglycemia. The participants in 
category 0 continued to exhibit hyperglycemia, while those in category 1 showed improvement in 
hyperglycemia (Ibaraki and Chiba, Japan: years 1999–2006). 20 
 
P P
Age (years) 49.5 ± 8.4 49.9 ± 8.7
Body mass index (kg/m2) 28.9 ± 2.9 26.0 ± 3.0 <0.001 28.5 ± 2.6 24.9 ± 2.6 <0.001
Waist circumference (cm) 97.7 ± 7.7 91.0 ± 7.8 <0.001 97.6 ± 7.6 88.3 ± 7.6 <0.001
Visceral fat area (cm2) 123 ± 51 93 ± 43 <0.001 113 ± 40 75 ± 31 <0.001
Systolic blood pressure (mmHg) 141 ± 21 128 ± 18 <0.001 137 ± 17 123 ± 15 <0.001
Diastolic blood pressure (mmHg) 87 ± 11 81 ± 11 <0.001 85 ± 10 76 ± 10 <0.001
Triglycerides (mg/dL) 122 ± 64 90 ± 41 <0.001 130 ± 102 75 ± 34 <0.001
High-density lipoprotein cholesterol (mg/dL) 59 ± 16 59 ± 14 not significant 62 ± 13 63 ± 12 not significant
Fasting plasma glucose (mg/dL) 99 ± 17 94 ± 14 <0.001 104 ± 27 92 ± 14 <0.001
Number of metabolic syndrome components 1.9 ± 0.8 1.2 ± 0.9 <0.001 1.9 ± 0.9 0.7 ± 0.8 <0.001
Number (%) of subjects with
  Abdominal obesity <0.001 <0.001
  Dyslipidemia <0.01 <0.001
  Hypertension <0.001 <0.001
  Hyperglycemia <0.05 <0.001
  Metabolic syndrome <0.001 <0.001
Values are mean ± standard deviation. Using the Japanese criteria of metabolic syndrome, prevalence of metabolic syndrome and its components
were evaluated: (i) abdominal obesity (visceral fat area ≥ 100 cm2 and/or waist circumference ≥ 90 cm), (ii) dyslipidemia (triglycerides ≥ 150
mg/dL and/or high-density lipoprotein cholesterol < 40 mg/dL), (iii) hypertension (systolic blood pressure ≥ 130 mmHg and/or diastolic blood
pressure ≥ 85 mmHg), and (iv) hyperglycemia (fasting plasma glucose ≥ 110 mg/dL). Metabolic syndrome was defined as having abdominal
obesity along with any two of the (ii) to (iv). Number of the metabolic syndrome components (0-4) was also counted.
Low-calorie diet
(n  = 115)
78 (67.8) 45 (39.1)
21 (18.3) 11 (9.6) 36 (18.6) 15 (7.7)
16 (13.9)
Low-calorie diet plus exercise
(n  = 194)
Table 1
Descriptive characteristics of subjects at baseline and after intervention. (Ibaraki and Chiba, Japan: years 1999-2006)
92 (80.0) 61 (53.0)
Baseline After
51 (26.3) 9 (4.6)
148 (76.3) 69 (35.6)
32 (27.8)
Baseline After
125 (64.4) 42 (21.6)
41 (21.1) 4 (2.1)28 (24.3) 7 (6.1)
Figure 1
563 Women underwent baseline assessment
240 Excluded
BMI < 25 kg/m2 (n = 130)
BMI > 40 kg/m2 (n = 3)
Absence of any components of MS (n = 82)
Incomplete assessment (n = 25)
118 Low-calorie diet 205 Low-calorie diet plus exercise
323 Non-randomized
Figure 2
Metabolic syndrome components
Category
0
1
Total
n
84
225
309
%
27.2
72.8
100.0
% loss of weight
Improvement = 0.039
Category
0
1
Total
n
33
26
59
%
55.9
44.1
19.1
<8.1%
Category
0
1
Total
n
51
199
250
%
20.4
79.6
80.9
≥8.1%
Baseline BMI
Improvement = 0.005
Category
0
1
Total
n
3
37
40
%
7.5
92.5
12.9
≤25.85 kg/m2
Category
0
1
Total
n
48
162
210
%
22.9
77.1
68.0
>25.85 kg/m2
P < 0.001
P′ < 0.05
Abdominal obesity
Category
0
1
Total
n
17
65
82
%
20.7
79.3
40.4
Category
0
1
Total
n
62
28
90
%
68.9
31.1
44.3
Category
0
1
Total
n
69
52
121
%
57.0
43.0
59.6
Category
0
1
Total
n
86
117
203
%
42.4
57.6
100.0
Category
0
1
Total
n
1
41
42
%
2.4
97.6
20.7
Category
0
1
Total
n
16
24
40
%
40.0
60.0
19.7
Category
0
1
Total
n
7
24
31
%
22.6
77.4
15.3
% loss of weight
Improvement = 0.063
<13.0%
Baseline BMI
Improvement = 0.049
>26.89 kg/m2
≥13.0%
Baseline age
Improvement = 0.029
≤52.5 years >52.5 years ≤26.89 kg/m2
P < 0.001
P′ < 0.001 P < 0.001
Figure 3
Category
0
1
Total
n
62
64
126
%
49.2
50.8
52.5
Low-calorie diet plus exercise
Category
0
1
Total
n
9
26
35
%
25.7
74.3
14.6
≤41.5 years
Category
0
1
Total
n
56
23
79
%
70.9
29.1
32.9
Low-calorie diet
Hypertension
Category
0
1
Total
n
127
113
240
%
52.9
47.1
100.0
Baseline age
Improvement = 0.025
P < 0.001
Category
0
1
Total
n
118
87
205
%
57.6
42.4
85.4
>41.5 years
Weight-loss program
Improvement = 0.019
P < 0.01
Figure 4
Figure 5
Hyperglycemia
Category
0
1
Total
n
23
34
57
%
40.4
59.6
100.0
% loss of weight
Improvement = 0.081
Category
0
1
Total
n
22
20
42
%
52.4
47.6
73.7
<13.2%
Category
0
1
Total
n
1
14
15
%
6.7
93.3
26.3
≥13.2%
P′ < 0.01
